Skip to content

Evaluation value of PET-MR in bone metastasis of prostate cancer

Evaluation value of PET-MR in bone metastasis of prostate cancer

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2200063088
Enrollment
Unknown
Registered
2022-08-30
Start date
2022-08-30
Completion date
Unknown
Last updated
2023-04-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

PET-MR

Interventions

Gold Standard:All patients met the relevant diagnostic criteria for PC in the European Society of Urogenital Radiology. All patients were diagnosed as PC by pathological puncture, and the tumor was vi
patients&#32
were&#32
by&#32
PET-MR&#32
with&#32
machine&#32
in&#32
Germany.&#32
Syngo&#32
True&#32
workstation&#32
was&#32

Sponsors

Jinshazhou Hospital, Guangzhou University of Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
36 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. All patients met the relevant diagnostic criteria for PCa in the European Society of Genitourinary Radiology, and were diagnosed as PCa by pathological puncture, and the tumor was visible and clearly displayed; 2. PET-MR examination before pathological puncture, the image data is intact and the image quality is good; 3. Without surgical resection, chemotherapy, radiotherapy and other relevant information; 4. Patients and their family members are well-informed, have good compliance, can cooperate with examination and treatment, and sign the informed consent form.

Exclusion criteria

Exclusion criteria: 1. Patients with other malignant tumors; 2. Patients with severe dysfunction of vital organs; 3. Existing bone-related diseases in the past; 4. The patient was complicated with severe systemic infection when he was hospitalized.

Design outcomes

Primary

MeasureTime frame
The maximum standard uptake value of local lesions;Prostate Cancer Pathological Grading;

Countries

China

Contacts

Public ContactWei He

Jinshazhou Hospital, Guangzhou University of Chinese Medicine

heweideor@21cn.com+86 15696281925

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026